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Introduction {#oby22560-sec-0005}
============

The prevalence of cardiovascular disease, hypertension, dyslipidemia, and type 2 diabetes is higher in individuals with obesity compared with lean individuals. With more than 650 million adults with obesity worldwide, more needs to be done to curb this pandemic. An emerging strategy capitalizes on brown adipose tissue (BAT) after the rediscovery of functional BAT in human adults [1](#oby22560-bib-0001){ref-type="ref"}, [2](#oby22560-bib-0002){ref-type="ref"}, [3](#oby22560-bib-0003){ref-type="ref"}. Activated BAT dissipates heat energy via nonshivering thermogenesis and contributes to energy expenditure (EE). Because BAT depots are sited fairly deep within the body, noninvasive imaging has been the preferred method of detection. Fluorine‐18 fluorodeoxyglucose (^18^F‐FDG) positron emission tomography (PET) imaging has most commonly been used in combination with computed tomography (CT) to study and detect the metabolic activity of BAT [1](#oby22560-bib-0001){ref-type="ref"}. Because of concerns over radiation exposure, longitudinal PET‐CT scanning for BAT studies in healthy individuals and children is not feasible. Other imaging methods, notably the magnetic resonance imaging (MRI) Dixon technique and infrared thermography (IRT), have been developed to facilitate noninvasive measurements of BAT without ionizing radiation [4](#oby22560-bib-0004){ref-type="ref"}, [5](#oby22560-bib-0005){ref-type="ref"}. In adult humans, the dominant area of BAT is in the supraclavicular region [6](#oby22560-bib-0006){ref-type="ref"}, [7](#oby22560-bib-0007){ref-type="ref"}. Activated BAT raises the anterior supraclavicular temperature (Tscv), which is detectable by IRT. Tscv, measured by IRT, is correlated to maximal glucose uptake on PET‐CT images [8](#oby22560-bib-0008){ref-type="ref"}. MRI can measure fat fraction (FF ‐ defined as the proportion of the acquired signal derived from fat protons) and $T_{2}^{\ast}$, which differ between BAT and WAT because of the former's high intracellular and extracellular water content and because of differences in vasculature and mitochondria [9](#oby22560-bib-0009){ref-type="ref"}, [10](#oby22560-bib-0010){ref-type="ref"}, [11](#oby22560-bib-0011){ref-type="ref"}, [12](#oby22560-bib-0012){ref-type="ref"}, [13](#oby22560-bib-0013){ref-type="ref"}.

Cold exposure is by far the most potent stimulus for BAT, and EE is increased after BAT activation [14](#oby22560-bib-0014){ref-type="ref"}. Capsinoids are capsaicin analogs found in nonpungent types of chili peppers [15](#oby22560-bib-0015){ref-type="ref"}. Dietary supplementation with capsinoids also leads to an increase in EE in adult humans via BAT activation [16](#oby22560-bib-0016){ref-type="ref"}, [17](#oby22560-bib-0017){ref-type="ref"}. In our previous report, we found that EE was significantly increased after cold exposure and capsinoid ingestion in BAT‐positive participants assessed through ^18^F‐FDG PET [18](#oby22560-bib-0018){ref-type="ref"}. The specific aim of this study was to evaluate BAT via a trimodality imaging approach, namely PET, magnetic resonance (MR), and IRT, coupled with EE via whole‐body calorimetry (WBC) after BAT activation using capsinoid ingestion and cold stimuli. An important objective was to evaluate whether MR and/or IRT can serve as effective nonionizing alternatives to PET.

Methods {#oby22560-sec-0006}
=======

Participants {#oby22560-sec-0007}
------------

This prospective study, conducted from August 2016 to March 2017, involved healthy participants without type 2 diabetes mellitus and cardiovascular diseases. Current smokers and persons with special diets or on medications known to alter BAT metabolism were excluded. Participants had to be clinically and biochemically euthyroid, as confirmed by serum thyrotropin and free thyroxine concentrations within the normal ranges. The study was done in a tropical country with an equatorial climate characterized by relatively stable outdoor ambient temperatures and with a relatively stable day length across the entire year and was conducted according to the ethical guidelines of the Declaration of Helsinki. The Domain‐Specific Review Board of National Healthcare Group, Singapore, approved all procedures, and the study was registered on ClinicalTrials.gov (TACTICAL‐II, identifier NCT02964442). Written informed consent was obtained from all participants before participation.

Study design {#oby22560-sec-0008}
------------

The participants attended two separate visits for PET‐MR and two separate visits for WBC/IRT to assess the effects of capsinoid ingestion and cold exposure. Visits were separated by a minimum washout period of 48 hours to minimize carry‐over effects. Capsinoid capsules (12 mg; eight gel capsules) were provided by Ajinomoto Co., Inc. (Tokyo, Japan). The composition details were described previously [19](#oby22560-bib-0019){ref-type="ref"}. Cold stimulation was achieved using a cooling vest with a fixed temperature of 14.5°C (Polar Products, Stow, Ohio). The participants were asked to refrain from caffeine and alcohol intake and any vigorous physical activity a day before the study. The study protocol and flowchart were described previously [18](#oby22560-bib-0018){ref-type="ref"}.

Screening measurements {#oby22560-sec-0009}
----------------------

Standing height (in meters) was measured with a stadiometer, and body weight (in kilograms) was measured with a bioelectrical impedance analysis device (Tanita BC‐418; Tanita Corp., Tokyo, Japan), which also includes a digital weighing scale. Body fat, fat mass, and fat‐free mass were measured by dual‐energy x‐ray absorptiometry (QDR 4500A; Hologic, Inc., Waltham, Massachusetts).

Blood analysis {#oby22560-sec-0010}
--------------

Screening blood samples were sent for renal, liver and thyroid function tests. High‐density lipoprotein (HDL), triglycerides (TG), fasting glucose, and fasting insulin were measured using the Cobas e311 analyzer (Roche Diagnostics, Basel, Switzerland). Serum nonesterified fatty acids (NEFA) were measured by using a commercially available enzymatic colorimetric assay (Wako Chemicals, Osaka, Japan). Homeostatic model assessment of insulin resistance (HOMA‐IR) was measured from fasting insulin and fasting glucose as (fasting insulin \[microunits per milliliter\]) × fasting glucose \[millimoles per liter\])/22.5.

EE and IRT {#oby22560-sec-0011}
----------

Participants, wearing light cotton singlets and Bermuda shorts only, were seated in an upright posture on a chair with their head positioned neutrally and their arms adducted. A thermal‐imaging camera (FLIR T440; FLIR Systems, Wilsonville, Oregon) was mounted on a tripod, placed in front of the participant, and positioned at neck height, 1 m from the participant's face. After a 10‐minute acclimatization period and a 45‐minute measurement of the baseline resting metabolic rate, baseline thermal images were recorded. After the baseline measurement, participants were asked to ingest the capsinoid capsules during the first WBC/IRT visit, or to wear the cooling vest during the second WBC/IRT visit, inside the WBC room for a 2‐hour measurement. The cooling vest was wrapped around the torso, leaving the anterior supraclavicular region exposed. All IRT video recordings were acquired over a standardized recording period of 1 second (30 frames per second), whereby anterolateral views of the anterior supraclavicular region were captured bilaterally. The thermal images were recorded every 15 minutes for 2 hours. The participants were requested to remain as still as possible with their shoulders apposed squarely against the back of the chair to minimize movement within the image frames during thermal video recordings. Thermal imaging was performed in the same room as the WBC EE measurements at a constant ambient temperature of 24ºC. Resting metabolic rate and change in EE during the 2‐hour intervention were calculated based on methodology established in a previous study [20](#oby22560-bib-0020){ref-type="ref"}.

PET‐MR {#oby22560-sec-0012}
------

After fasting for 10 to 12 hours, the participants arrived at the Clinical Imaging Research Centre. An indwelling cannula was inserted into a forearm vein by a registered nurse after a 10‐minute rest, and fasting blood glucose was measured. During the first visit, participants were asked to ingest capsinoids 30 minutes before the scan. During the second visit, participants were asked to wear the cold vest after arrival. Because of the logistics of scanner availability, the duration of the prescan cooling was not fixed and ranged between 51 and 162 minutes. During both visits, participants were given an intravenous injection of ^18^F‐FDG (3 mCi) 20 minutes before the start of the scans. The scans were performed on a hybrid 3‐T PET‐MR system (Biograph mMR; Siemens Healthineers, Erlangen, Germany) for 80 minutes. Three‐dimensional (3D) T2‐weighted anatomical images were acquired using the following: repetition time (TR) = 1,300 milliseconds; echo time (TE) = 120 milliseconds; field of view = 384 mm × 384 mm; and matrix size = 192 × 192. A 3D multipoint (10 echoes) Dixon sequence was used for the water‐fat imaging at the start and end of the scan with the following parameters: TR = 15 milliseconds; 10 echo times = 1.23, 2.46, 3.69, 4.92, 6.15, 7.38, 8.61, 9.84, 11.07, and 12.30 milliseconds; flip angle = 4°; field of view = 384 mm × 384 mm; matrix size = 192 × 192; bipolar readout mode and 112 sections with 2‐mm thickness. Total acquisition time for the multipoint Dixon sequence was approximately 4.49 minutes. All imaging sequences had anatomical coverage of the neck, supraclavicular region, and the apexes of the lung.

Analysis of IRT {#oby22560-sec-0013}
---------------

Recorded as a radiometric infrared video using the FLIR ResearchIR software version 3.3 (FLIR Systems, Wilsonville, Oregon), the thermal data were analyzed with a modified seeded region growing technique using a semiautomated algorithm to detect the hot regions overlaying the supraclavicular brown adipose tissue (sBAT). At the start of the algorithm, a bounding box encompassing likely sBAT depots was manually drawn on the first frame of the infrared video, from which the pixel of the maximum temperature value was automatically selected as the "seed." The seed initialized the region of interest (ROI), which was iteratively grown by comparing all unallocated neighboring pixels to the region. A fixed threshold was optimized for all the participants to achieve reliable segmentation. With the same algorithm, all frames in a single infrared video were calibrated by detecting and using circular aluminum foil disks that were placed on the subject's skin (diameter of 5 mm; four on the upper thorax demarcated by 5 × 5 cm^2^). The temperature of the skin overlying the sternum, a region devoid of BAT, served as a good reference. The median frame out of the 1‐second (30 frames) video was subsequently used to represent the particular time point at which the video was taken and the ROI calculated. The ROI of the hot region, as delineated by this algorithm, served to identify potential sBAT depots.

Analysis of PET‐MR {#oby22560-sec-0014}
------------------

The multi‐echo complex data were fitted using Levenberg‐Marquardt nonlinear fitting and using the seven‐peak fat model with the following equations:$$\left| S_{n} \right| = \left| {\left( {M_{w} + c_{n}M_{f}} \right) \cdot e^{- R_{2eff}^{\ast}TE_{n}}} \right|;\, and$$ $$\left| S_{n} \right| = \left| \left( {M_{w} \cdot e^{- R_{2w}^{\ast}TE_{n}} + c_{n}M_{f} \cdot e^{- R_{2f}^{\ast}TE_{n}}} \right) \right|.$$

$R_{2w}^{\ast}$ and $R_{2f}^{\ast}$ are the $R_{2}^{\ast}$ of water and fat independently, and $R_{2eff}^{\ast}$ is the effective $R_{2}^{\ast}$ of both water and fat; c~n~ is the complex coefficient, defined as $c_{n} = \sum_{1}^{7}{w_{i}e^{j(2\pi\Delta f_{i}TE_{n})}}$, for a seven‐peak fat model; and *w* ~i~ and *f~i~* are the weighting factor and the resonance frequency offset of the fat peak, respectively [21](#oby22560-bib-0021){ref-type="ref"}. The initial guesses for the water and fat signal fraction were obtained based on the Dixon composition of the first two echoes. A multi‐step adaptive nonlinear fitting approach was used to update the water and fat signal fraction and $R_{2}^{\ast}$ values [22](#oby22560-bib-0022){ref-type="ref"}. Pixelwise quantification of FF was performed from fat and water maps. The standardized uptake value (SUV) was calculated as previously described [23](#oby22560-bib-0023){ref-type="ref"}.

An affine‐based registration method was used to register MR and PET images [24](#oby22560-bib-0024){ref-type="ref"}. The initial mask was generated by the rolling ball background subtraction algorithm followed by the percentile‐based automatic thresholding method. Erosion and dilation were performed to remove the extra unwanted regions and to fill the holes inside the initial mask [25](#oby22560-bib-0025){ref-type="ref"}. The final mask was applied to exclude the unwanted region and background from MR and PET images. sBAT depots were manually segmented based on anatomical information in multiple section images of registered MR and PET images using ITK‐SNAP (version 3.6.0) and under close guidance of an experienced radiologist [26](#oby22560-bib-0026){ref-type="ref"}. A lower threshold of 40% of FF values was used to exclude the muscle and bone marrow [27](#oby22560-bib-0027){ref-type="ref"}.

Integration of PET, MR, and IRT {#oby22560-sec-0015}
-------------------------------

A 3D‐volume rendering of MR and PET images was performed using α blending [28](#oby22560-bib-0028){ref-type="ref"}. A one‐dimensional transfer function was defined using the α (luminance) of each voxel of the volume, with an optimal global offset for better visualization. The optimal two‐dimensional (2D) projection was obtained in coronal orientation by navigating through MR and PET volumes. The IRT map was selected based on the maximum mean temperature in the sBAT region. The IRT map was wrapped on to the 2D overlaid image of PET‐MR. Control‐point pairs were identified manually based on the anatomical location of sBAT, left and right superolateral apexes, acromioclavicular apexes, and sternal apex using the *cpselect* function of MATLAB 2016b (MathWorks, Natick, Massachusetts) from IRT, MR, and PET and their edge images. The *Fitgeotrans* function was used to wrap the IRT and PET‐MR maps using the *affine* transformation model. Finally, the wrapped IRT map was overlaid on the PET‐MR data to visualize the overlap of the hottest sBAT region and maximal glucose uptake.

Data analysis {#oby22560-sec-0016}
-------------

The association among the relevant variables was examined using the Pearson correlation. We performed a confirmatory analysis using a generalized structural equation model [29](#oby22560-bib-0029){ref-type="ref"}, while taking the different visits and sequence of measurements into account. The analysis was adjusted with the duration of cold exposure and demographics (sex, age, body weight, and percentage of body fat). The FF was measured at the start and end of the scan (80 minutes), whereas the SUV was integrated over the 80‐minute scan on the same visit. The IRT Tscv was measured at baseline, peak, and 120 minutes on a separate visit. We used the linear mixed‐effects model to evaluate the main effects of the treatment type (capsinoids vs. cold exposure) and to evaluate the BAT status of participants (BAT‐positive vs. BAT‐negative) as well as their interactions, while controlling for baseline measurements. Data are presented as mean (SEM) unless otherwise stated. *P* \< 0.05 was considered statistically significant. A statistical analysis was performed in Stata software MP version 14.0 (StataCorp LLC, College Station, Texas) for the confirmatory analysis, and another statistical analysis was performed in SPSS Statistics software version 23 (IBM Corp., Armonk, New York).

Results {#oby22560-sec-0017}
=======

Characteristics of participants {#oby22560-sec-0018}
-------------------------------

The data of 20 healthy participants (age: 25.9 \[4.1\] years; number of male participants: 8) were analyzed. Their BMI and body fat percentage were 21.7 (2.5) and 29.2% (8.0%), respectively (Table [1](#oby22560-tbl-0001){ref-type="table"}). There was a significant sex difference in body weight (male participants: 70.5 \[12.7\] kg vs. female participants: 57.1 \[9.8\] kg; *P* = 0.02). The female participants were found to have a significantly higher body fat percentage than their male counterparts (33.2% \[6.3%\] vs. 23.4% \[6.6%\]; *P* \< 0.004). PET‐MR data from two female participants were not included because of their motion during part of the MR scan, which led to inaccurate FF computations. Thus, the FF map was analyzed with only 18 participants. Other analyses that did not require the FF map were done on the full sample of 20 participants.

###### 

Participant characteristics[a](#oby22560-note-0006){ref-type="fn"}

                                                            All participants   Male participants   Female participants   *P* value[b](#oby22560-note-0007){ref-type="fn"}
  --------------------------------------------------------- ------------------ ------------------- --------------------- --------------------------------------------------
  ***n***                                                   20                 8                   12                    ...
  **Age, y**                                                25.9 ± 4.1         25.8 ± 4.1          25.9 ± 4.3            NS
  **Height, cm**                                            168.5 ± 8.9        175.0 ± 5.4         164.2 ± 8.2           0.004
  **Weight, kg**                                            62.5 ± 12.6        70.5 ± 12.7         57.1 ± 9.8            0.015
  **BMI** [c](#oby22560-note-0008){ref-type="fn"}           21.7 ± 2.5         22.9 ± 3.0          20.9 ± 1.8            NS
  **Body fat, %**                                           29.2 ± 8.0         23.4 ± 6.6          33.2 ± 6.3            0.004
  **Fat mass, kg**                                          18.4 ± 7.5         17.1 ± 7.6          19.3 ± 7.6            NS
  **Fat‐free mass, kg**                                     43.6 ± 9.5         53.0 ± 6.9          37.4 ± 4.3            \<0.001
  **RMR, kcal/d** [d](#oby22560-note-0009){ref-type="fn"}   1,533 ± 271.0      1,752.5 ± 245.5     1,386.7 ± 173.6       0.001

Values are mean ± SEM.

*P* values represent Student *t* test between male and female participants.

BMI calculated as body weight (in kilograms) divided by height (in meters squared).

Values represent average RMR from two whole‐body calorimeter study visits.

NS, not significant; RMR, resting metabolic rate.

John Wiley & Sons, Ltd

BAT imaging using PET, MR, and IRT, which show area overlaps {#oby22560-sec-0019}
------------------------------------------------------------

Representative images of PET, MR, and IRT from a participant after cold exposure and capsinoid ingestion are shown in Figure [1](#oby22560-fig-0001){ref-type="fig"}. The ROI around the sBAT was drawn on a coregistered T2‐weighted anatomical image showing the FF and SUV maps (Figure [1](#oby22560-fig-0001){ref-type="fig"}A‐[1](#oby22560-fig-0001){ref-type="fig"}C). The PET images were overlaid on anatomical MR images (Figure [1](#oby22560-fig-0001){ref-type="fig"}D) to achieve better visualization and functional information. IRT images (Figure [1](#oby22560-fig-0001){ref-type="fig"}E) also showed higher temperatures after cold exposure compared with after capsinoid ingestion. The 2D projected PET image overlaid on the MR projected image is shown in Figure [1](#oby22560-fig-0001){ref-type="fig"}F, with the ROI showing maximum glucose uptake around sBAT. The uptake was higher after cold exposure compared with after capsinoid ingestion. The ROI was drawn to show the maximum temperature within sBAT on the wrapped IRT image, as shown in Figure [1](#oby22560-fig-0001){ref-type="fig"}G. The overlaid image of IRT and PET‐MR (Figure [1](#oby22560-fig-0001){ref-type="fig"}H) highlights the maximum glucose uptake and hottest regions within sBAT. A significant anatomical overlap of the hottest regions and maximal glucose update was observed.

![Representative images of a brown adipose tissue (BAT)--positive participant after cold exposure and capsinoid ingestion. (**A,B,C**) T2‐weighted anatomical image showing the supraclavicular brown adipose tissue (sBAT), the fat fraction (FF) map in which sBAT is highlighted (color scale shows values of FF in percentages), and the fluorine‐18 fluorodeoxyglucose (^18^F‐FDG) positron emission tomography (PET) map with a color scale showing standardized uptake values (SUV). (**D**) PET overlaid on the magnetic resonance (MR) image. (**E**) Infrared thermography (IRT) map with a color bar showing the temperature in degrees Celsius. (**F**) 2D projected PET image overlaid on the MR image, with the regions of interest (ROI) showing the maximum glucose uptake within sBAT. (**G**) Wrapped IRT image on the PET‐MR image, with ROI showing the maximum temperature within sBAT. (**H**) Overlaid images of IRT and PET‐MR highlighting the maximum glucose uptake (red) and hot (yellow) regions within sBAT.\[Colour figure can be viewed at <http://wileyonlinelibrary.com>\]](OBY-27-1434-g001){#oby22560-fig-0001}

BAT imaging assessments before and after capsinoids and cold {#oby22560-sec-0020}
------------------------------------------------------------

The BAT imaging parameters from the three modalities before and after the interventions for all the participants are shown in Table [2](#oby22560-tbl-0002){ref-type="table"}. We also evaluated these parameters after stratifying the participants into BAT‐positive and BAT‐negative groups based on the PET uptake, as defined previously [18](#oby22560-bib-0018){ref-type="ref"}. The mean cutoff SUV for dividing participants into BAT‐positive and BAT‐negative groups was 2.0. In BAT‐positive, but not in BAT‐negative, participants, the SUV after cold exposure was significantly higher versus after capsinoid ingestion. There was significant interaction between treatment and participant status (*P* = 0.022). The rest of the variables (FF, Tscv, and EE) had no significant interaction between treatment and participant status. The respective main effects of treatment and of participant status are reported in Table [3](#oby22560-tbl-0003){ref-type="table"}.

###### 

Summary of outcomes of SUV, FF, IRT Tscv, IRT Tref, and EE after capsinoid ingestion and cold exposure in all participants[a](#oby22560-note-0011){ref-type="fn"}

                      Capsinoid ingestion                                       Cold exposure
  ------------------- --------------------------------------------------------- ---------------------------------------------------------
  **SUV**             1.07 ± 0.05                                               1.51 ± 0.18[b](#oby22560-note-0012){ref-type="fn"}
  **FF (%)**                                                                     
  **Start of scan**   76.30 ± 1.36                                              74.59 ± 1.55
  **End of scan**     74.63 ± 1.33                                              75.33 ± 1.54
  **IRT Tscv (°C)**                                                              
  **Baseline**        35.28 ± 0.09                                              35.30 ± 0.10
  **120 minutes**     35.23 ± 0.10                                              35.25 ± 0.14
  **IRT Tref (°C)**                                                              
  **Baseline**        33.46 ± 0.20                                              33.56 ± 0.13
  **120 minutes**     33.73 ± 0.18                                              32.18 ± 0.55[c](#oby22560-note-0013){ref-type="fn"}
  **EE (kcal/d)**                                                                
  **Baseline**        1,529.85 ± 61.19                                          1,567.50 ± 70.74
  **120 minutes**     1,648.55 ± 62.96[c](#oby22560-note-0013){ref-type="fn"}   1,775.10 ± 77.46[c](#oby22560-note-0013){ref-type="fn"}

Values are mean ± SEM; SUV and FF values calculated from 18 participants; IRT Tscv, IRT Tref, and EE values calculated from 20 participants.

Different from capsinoid ingestion; tested using paired *t* test; *P* \< 0.05.

Different from baseline within same treatment group; tested using paired *t* test; *P* \< 0.05.

Tref, chest reference temperature; EE, energy expenditure; FF, fat fraction; IRT, infrared thermography; SUV, standardized uptake value; Tref, chest reference temperature; Tscv, anterior supraclavicular temperature.
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###### 

Summary of outcomes of SUV, FF, IRT Tscv, IRT Tref, and EE after capsinoid ingestion and cold exposure in BAT‐positive and BAT‐negative participants

                      BAT‐positive participants   BAT‐negative participants                            Treatment effects, *P* [b](#oby22560-note-0018){ref-type="fn"}   Participant status effects, *P* [b](#oby22560-note-0018){ref-type="fn"}   Treatment × participant status interactions, *P* [b](#oby22560-note-0018){ref-type="fn"}             
  ------------------- --------------------------- ---------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ --------- -------
  **SUV**             1.08 ± 0.06                 1.78 ± 0.24[a](#oby22560-note-0017){ref-type="fn"}   1.07 ± 0.11                                                      1.00 ± 0.11                                                               0.053                                                                                      0.082     0.022
  **FF (%)**                                                                                                                                                                                                                                      0.524                                                                                      0.735     0.163
  **Start of scan**   77.22 ± 1.80                74.67 ± 2.06                                         74.47 ± 1.92                                                     75.40 ± 2.00                                                              ...                                                                                        ...       ...
  **End of scan**     74.34 ± 1.83                74.85 ± 2.15                                         75.17 ± 1.81                                                     76.23 ± 2.05                                                              ...                                                                                        ...       ...
  **IRT Tscv (°C)**                                                                                                                                                                                                                               0.795                                                                                      0.143     0.221
  **Baseline**        35.33 ± 0.08                35.33 ± 0.06                                         35.19 ± 0.21                                                     35.25 ± 0.23                                                              ...                                                                                        ...       ...
  **120 minutes**     35.31 ± 0.08                35.40 ± 0.13                                         35.10 ± 0.22                                                     35.04 ± 0.27                                                              ...                                                                                        ...       ...
  **IRT Tref (°C)**                                                                                                                                                                                                                                                                                                                                     
  **Baseline**        33.50 ± 0.28                33.50 ± 0.17                                         33.41 ± 0.30                                                     33.64 ± 0.20                                                              ...                                                                                        ...       ...
  **120 minutes**     33.74 ± 0.26                32.08 ± 0.85                                         33.71 ± 0.23                                                     32.33 ± 0.58                                                              ...                                                                                        ...       ...
  **EE (kcal/d)**                                                                                                                                                                                                                                 0.005                                                                                      \<0.001   0.146
  **Baseline**        1,486.50 ± 95.64            1,573.75 ± 87.98                                     1,558.75 ± 81.91                                                 1,558.13 ± 125.27                                                         ...                                                                                        ...       ...
  **120 minutes**     1,706.33 ± 80.22            1,840.58 ± 100.91                                    1,561.88 ± 99.71                                                 1,676.88 ± 120.06                                                         ...                                                                                        ...       ...

SUV calculated from PET, integrated in 80 minutes, and coregistered with MR in region of interest supraclavicular area; FF from MR at start of scan was 20 minutes after capsinoid ingestion or 1 to 2 hours of cold exposure. End of scan calculated at end of 80 minutes; Tscv, Tref, and EE obtained at baseline and at end of study at 120 minutes in whole‐body calorimetry/IRT sessions.

Values are mean ± SEM; SUV and FF values calculated from 18 participants (11 BAT‐positive participants and 7 BAT‐negative participants); IRT Tscv, IRT Tref, and EE values calculated from 20 participants (12 BAT‐positive participants and 8 BAT‐negative participants).

Different from capsinoid ingestion; tested using paired *t* test; *P* \< 0.05.

Treatment effects, participant status effects, and interactions between treatment and participant status were tested using linear mixed‐effects model, controlling for baseline measurements.

BAT, brown adipose tissue; EE, energy expenditure; FF, fat fraction; IRT, infrared thermography; MR, magnetic resonance; PET, positron emission tomography; SUV, standardized uptake value; Tref, chest reference temperature; Tscv, anterior supraclavicular temperature.
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BAT imaging assessments and EE {#oby22560-sec-0021}
------------------------------

The confirmatory analyses were adjusted for body weight only because it was significantly associated with EE at 2 hours. After cold exposure, Tscv at 2 hours was found to have a positive and significant (*P* = 0.025) correlation with EE at 2 hours, with adjustment for body weight and duration of cold exposure. Other things being equal, a 1°C increase in Tscv reflected an increase in EE by almost 206 kcal/d (Table [4](#oby22560-tbl-0004){ref-type="table"}). However, after capsinoid ingestion, Tscv did not show any significant correlation with EE at 2 hours, with adjustment for body weight (Table [4](#oby22560-tbl-0004){ref-type="table"}). The SUV and FF did not show any significant association with EE after both capsinoid ingestion and cold exposure.

###### 

Regression results of EE with imaging parameters (SUV, FF, and IRT Tscv) after capsinoid ingestion and cold exposure

                         Capsinoid ingestion   Cold exposure                                                     
  ---------------------- --------------------- ---------------------- --------- ---------- --------------------- ---------
  **SUV**                218.5                 −298.9 to 735.8        0.382     17.2       −165.5 to 199.9       0.843
  **Body weight (kg)**   14.8                  6.2 to 23.4            0.002     19.9       9.5 to 30.2           0.001
  **Constant**           477.6                 −89.6 to 1,044.7       0.093     482.7      −153.0 to 1,118.4     0.126
  **FF (%)**             −1.94                 −20.9 to 17.0          0.83      −1.87      −27.7 to 23.9         0.88
  **Body weight (kg)**   16.7                  8.9 to 24.6            \<0.001   19.8       7.4 to 32.2           0.004
  **Constant**           733.7                 −676.1 to 2,143.5      0.29      660.2      −1,034.4 to 2,354.8   0.42
  **Tscv (°C)**          156.3                 −47.7 to 360.2         0.124     205.5      28.6 to 382.4         0.025
  **Body weight (kg)**   18.1                  11.1 to 25.1           \<0.001   22.6       14.4 to 30.9          \<0.001
  **Constant**           −4,999.1              −12,331.1 to 2,332.9   0.11      −6,894.9   −13,311.4 to −478.5   0.037

SUV and FF values calculated from 18 participants; Tscv and EE values calculated from 20 participants. SUV, calculated from PET, was integrated in 80 minutes; FF, calculated from MR imaging, at end of the scan was integrated at 80 minutes; Tscv from IRT analysis was integrated in 120 minutes in supraclavicular region; and average EE was integrated in 120 minutes. Analysis adjusted with body weight (kilograms).

EE, energy expenditure; FF, fat fraction; IRT, infrared thermography; MR, magnetic resonance; PET, positron emission tomography; SUV, standardized uptake value; Tscv, anterior supraclavicular temperature.

John Wiley & Sons, Ltd

Effects of cold duration on SUV and FF {#oby22560-sec-0022}
--------------------------------------

The SUV after cold stimulation was not found to be associated with the duration of cold exposure (Figure [2](#oby22560-fig-0002){ref-type="fig"}A), whereas the FF was found to be negatively associated, as shown in Figure [2](#oby22560-fig-0002){ref-type="fig"}B. A significant negative correlation was found between SUV and the end‐of‐scan FF after we adjusted for body weight and duration of cold exposure (Figure [2](#oby22560-fig-0002){ref-type="fig"}C).

![Correlation between (**A**) standardized uptake value (SUV) and (**B**) fat fraction (FF) with duration of cold exposure in 18 participants. (**C**) Correlation between SUV and FF after adjustment for cold exposure duration and body weight in 18 participants.](OBY-27-1434-g002){#oby22560-fig-0002}

Relationship between PET SUV and maximum IRT Tscv after cold exposure {#oby22560-sec-0023}
---------------------------------------------------------------------

There was a statistically significant correlation between the PET SUV and the maximum Tscv (*r* = 0.651; *P* = 0.022). The correlation between PET the SUV against the Δ Tscv was just short of statistical significance (maximum Tscv− baseline Tscv) (*r* = 0.574; *P* = 0.051) (Figure [3](#oby22560-fig-0003){ref-type="fig"}).

![Correlations between the positron emission tomography (PET) mean standardized uptake value (SUV) and the (**A**) infrared thermography (IRT) maximum anterior supraclavicular temperature (Tscv max) and (**B**) Tscv max change from baseline (∆ Tscv max) in PET brown adipose tissue (BAT)--positive participants (*n* = 12).](OBY-27-1434-g003){#oby22560-fig-0003}

Relationship between imaging parameters and blood lipids and HOMA‐IR {#oby22560-sec-0024}
--------------------------------------------------------------------

Plasma NEFA was positively correlated with the SUV (*P* = 0.01). Plasma HDL and NEFA were negatively correlated with FF, whereas TG and FF were positively correlated after cold exposure. HOMA‐IR correlated positively with the FF of BAT (Table [5](#oby22560-tbl-0005){ref-type="table"}).

###### 

Summary of imaging parameters' relationship with blood metabolic markers after cold exposure

  Blood parameter     SUV     FF (%)   Tscv (°C)                 
  ------------------- ------- -------- ----------- ------ ------ ------
  **HDL (mmol/L)**    0.04    0.88     −0.52       0.02   0.19   0.41
  **TG (mmol/L)**     −0.11   0.68     0.52        0.04   0.07   0.78
  **NEFA (mmol/L)**   0.63    0.01     −0.58       0.01   0.21   0.41
  **HOMA‐IR**         −0.04   0.87     0.61        0.01   0.19   0.45

Correlations between imaging parameters and plasma concentration parameters at 120 minutes after cold exposure and HOMA‐IR, calculated on the cold‐exposure whole‐body calorimetry/infrared thermography visit, with adjustment for sex.

FF, fat fraction; HDL, high‐density lipoprotein; HOMA‐IR, homeostatic model assessment of insulin resistance; NEFA, nonesterified fatty acid; SUV, standardized uptake value; TG, triglyceride; Tscv, anterior supraclavicular temperature.

John Wiley & Sons, Ltd

Discussion {#oby22560-sec-0025}
==========

Adult humans have first been found to possess functional BAT dating back to more than 3 decades ago [30](#oby22560-bib-0030){ref-type="ref"}. During the era of the late 1970s and 1980s, functioning BAT was proven to exist in adult humans [31](#oby22560-bib-0031){ref-type="ref"}, [32](#oby22560-bib-0032){ref-type="ref"}. Enigmatically, the erroneous view that BAT is absent in adults perpetuated over many years, nonetheless, until the more recent simultaneous rediscovery of the presence of functional depots of BAT in humans [1](#oby22560-bib-0001){ref-type="ref"}, [2](#oby22560-bib-0002){ref-type="ref"}, [3](#oby22560-bib-0003){ref-type="ref"}, leading to a revival of interest in BAT as a potential target for increasing EE to combat metabolic disease. PET has already been instrumental in the identification of BAT in humans [33](#oby22560-bib-0033){ref-type="ref"} and is routinely used in functional characterization of BAT activity in rodents [34](#oby22560-bib-0034){ref-type="ref"}, [35](#oby22560-bib-0035){ref-type="ref"}. PET relies on the uptake of the radio‐labeled tracer 2‐deoxy‐2‐^18^F‐FDG, an analog of glucose, which is taken up by metabolically active tissues. However, the exposure to ionizing radiation limits the wider applicability of PET for investigating BAT activity in the general population.

This study was the first to measure BAT activity in humans using three imaging modalities, namely PET, MR, and IRT, after sympathetic nervous system activation via capsinoid ingestion and cold exposure. Our key finding was that participants identified as BAT‐positive and BAT‐negative by PET differed distinctively in both their thermal responses as well as their elevation of EE after cold exposure. BAT‐positive participants, but not BAT‐negative participants, had elevated EE after both capsinoid ingestion and cold exposure. Although both groups experienced a significant drop in the reference temperature after cold exposure, a trend exists in which the BAT‐positive participants were protected from a decline in Tscv. In the pooled participants, the Tscv after 2 hours of cold exposure also had significant correlation with EE, indicating that an increase in Tscv could provide a reliable estimate of EE increase after BAT activation. The SUV and high‐resolution, MR‐based FF imaging allowed supraclavicular and cervical BAT to be anatomically localized and visualized. IRT, being a surface imaging modality, offered limited insights into the localization and amount of BAT but was sensitive to functional BAT activity. The correlation between SUV and the maximum IRT Tscv is statistically significant, thereby supporting the use of IRT as an imaging modality for activated BAT.

In our experimental paradigm for cold exposure, participants wore the cooling vest before the PET‐MR scan but not during the scan because the vest was not MRI compatible. Because the ^18^F‐FDG uptake after cold exposure was suggestive of increased BAT activity in the BAT‐positive participants, we expected the FF to decline during the scan because of increased consumption of lipid substrates during BAT thermogenesis. To understand the lack of change in the FF between the start and end of the scan, we evaluated the association of the duration of cold exposure with the FF and SUV. We found that the FF, but not the SUV was inversely associated with the duration of cold exposure. These results suggest that cold may induce an initial spike in glucose uptake in BAT, but sustained cold exposure may increase reliance on fat as a substrate for thermogenesis. After controlling for the duration of cold exposure, the FF measured after cold exposure at the end of the scan at 80 minutes varied inversely with the SUV, consistent with previous studies [27](#oby22560-bib-0027){ref-type="ref"}, [36](#oby22560-bib-0036){ref-type="ref"}, [37](#oby22560-bib-0037){ref-type="ref"}, indicating that the FF is indeed related to functional BAT activity.

In addition to the role of dynamic changes in FF in evaluating BAT activity, the TG content of the supraclavicular depot has been found to be positively associated with insulin resistance and risk of diabetes [38](#oby22560-bib-0038){ref-type="ref"}. In concordance with this, we also found the FF after cold exposure to be positively associated with HOMA‐IR and TG and negatively associated with HDL cholesterol. We also found a negative association with NEFA levels, which could be a reflection of increased usage of plasma NEFA for BAT thermogenesis. Recent studies have investigated $T_{2}^{\ast}$ to evaluate differences between supraclavicular and gluteal adipose tissues and variable number of gradient echoes [13](#oby22560-bib-0013){ref-type="ref"}. In addition, the fat water spectral model, which includes susceptibility‐induced frequency variation has been evaluated [12](#oby22560-bib-0012){ref-type="ref"}. In this study, we did not investigate the metabolic correlation with $T_{2}^{\ast}$ values for BAT‐positive and BAT‐negative participants.

Capsinoid ingestion was linked to an increase in EE in BAT‐positive participants, although the ^18^F‐FDG uptake after capsinoid ingestion was notably low in both groups. Importantly, we had earlier published data supporting a subthreshold increase in the SUV after capsinoid ingestion [18](#oby22560-bib-0018){ref-type="ref"}. Neither group experienced any significant changes in Tscv or FF after capsinoid ingestion. These results indicate a low sensitivity for these three imaging modalities to detect functional changes in sBAT after capsinoid ingestion. More studies are required to ascertain if the sBAT activity in capsinoid‐induced elevation in EE is clinically significant.

Our study has a few limitations. The perceived fear of ionizing radiation associated with PET led to a small sample size, which limited the power to detect significant changes in the imaging parameters after different interventions. We also lacked a PET‐MR scan at ambient temperature to compare the difference between ambient temperature and cold exposure. The logistics of scanner availability led to a variation in cold exposure duration between participants. This probably contributed to the lack of correlation between the FF and maximum Tscv, which can be further explored in future studies. We only used the front Tscv to correlate with the SUV and FF, but this approach may miss BAT localized over the left and right neck regions. A more sophisticated IRT (e.g., 3D and four‐dimensional IRT with improved segmentation) might be required to assess changes in Tscv with finer details after BAT activation.

Our present study demonstrated the feasibility to detect BAT activation in both sexes by cold exposure and capsinoid ingestion using multiple imaging modalities: PET, MRI, and IRT. This sets the stage for future prospective BAT studies to elucidate sex differences. The anatomical information from MRI and functional information from IRT provide a nonionizing alternative to PET‐CT for BAT assessments. Radiometric sensors are now able to distinguish changes of 0.01ºC while the resolution of images is improving. Combined with an automated analysis, the variability of IRT between individuals should be further reduced. Given the low cost of IRT, the above improvements will be useful for establishing IRT as a valid method of measuring sBAT activity in the wider population. MRI also provides information beyond the anatomical localization of BAT. Although PET and IRT can only be used to assess the acute effect of thermogenic stimuli, the FF of the supraclavicular region can provide unique insight into longer‐term metabolic health.

Conclusion {#oby22560-sec-0026}
==========

IRT is a valid imaging method for BAT, in preference over PET‐CT. IRT has potential practical utility in terms of facilitating research in the evaluation of therapeutics (i.e., nutraceuticals and pharmaceuticals) in large clinical populations because it is of relatively low cost, is convenient, and is safe for serial applications. Successful establishment of IRT and MR FF as effective BAT imaging modalities will promote their use in the monitoring and follow‐up of BAT‐based interventions among patients and healthy populations.

Ajinomoto Co., Inc., provided the capsinoids but was not involved in the conception, design, or conduct of the study and did not influence the writing of this manuscript. Individual participant data or any other data will not be available.
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